Call to Action: Implementing the National Action Plan for Adverse Drug Event Prevention to Benefit Older Adults
Recorded: June 27, 2018
Speakers: Donna Lisi, PharmD, BCPS, BCPP, BCGP; Nicole Skyer-Brandwene MS, RPh, BCPS, CCP
This program will provide participants with evidence-based tools that they can use to help implement ADE mitigation strategies for older adults who are utilizing anticoagulants, hypoglycemic and opioid analgesics.
Description: This webinar will discuss the goals of the National Action Plan on Adverse Drug Event Prevention and efforts of local Quality Improvement Networks to encourage the implementation of strategies for risk mitigation for three high-risk classes of medications (anticoagulants, hypoglycemics and opioids). These classes of medication are often used by older adults for the management of chronic conditions but can lead to harm when adequate safeguards for their use are not put in place. Clinicians caring for older adults will learn about evidence-based tools and strategies that they can implement in their practice settings to help reduce ADEs in older adults utilizing these high-risk medications.
-Define the scope and risk factors for adverse drug events in older adults.
- Describe the National Action Plan for Adverse Drug Event Prevention and the role of Quality Improvement Networks in reducing ADEs in older adults.
- Identify strategies for surveillance, the utilization of evidence-based tools as promulgated through Quality Improvement Networks, incentivize safety, and research into adverse drug event prevention in older adults.
- Adapt the suggested approaches for adverse drug event harm reduction to older adults in various practice settings.
AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians. The Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
1.5 CME, 1.5 CMD clinical, 1.5 MOC
Dr. Donna Lisi has over 30 years' experience in the Geriatrics. After completing the BS in Pharmacy and Doctor of Pharmacy programs at St. John's University in NY, she finished a 2-1/2 year Geriatric Pharmacy fellowship at Montefiore Medical Center in the Bronx. Most recently, Dr. Lisi was a Scholar in the Geriatric Education Center's Faculty Development Collaborative Program. She has held faculty appointments at Philadelphia College of Pharmacy, the University of Louisiana at Monroe College of Pharmacy and several others. She was Clinical Pharmacist in Geriatrics for 7 years at the NJ VA Health Care System and discipline coordinator for both the New Jersey and Louisiana Geriatric Education Centers. For 16 years, Dr. Lisi authored clinical practice guidelines on proper medication use in the elderly for the Omnicare formulary.
Dr. Lisi is a Board-certified Pharmacotherapy Specialist, Board-certified Geriatric Pharmacist, and Board-certified Psychiatric Pharmacist. She is also a Certified Dementia Practitioner in addition to being Medication Therapy Management certified and Naloxone Administration certified.
Presently, Dr. Lisi is faculty at Union County College and is a freelance medical writer and educator. She has authored modules for the American Society of Consultant Pharmacists and American College of Clinical Pharmacy on medication-related topics. Dr. Lisi serves on the Somerset County Aging Advisory Council and is a member of the Quality Insight's Medication Action Team (MAT).
Nicole Skyer-Brandwene is the Network Task Lead for Adverse Drug Event Prevention for the Quality Insights-Quality Innovation Network. Funded by CMS, The Quality Insights Network includes New Jersey, Pennsylvania, Delaware, West Virginia and Louisiana. She is leading efforts to reduce adverse drug events associated with 3 high-risk classes of drugs-anticoagulants, diabetes drugs and opioids in Medicare beneficiaries. This work is part of a larger coordination of care effort with an emphasis on reducing avoidable hospitalizations and improving quality across the continuum of care. From 2009 to 2015 Nicole led various quality improvement initiatives including a community-based effort to reduce and manage warfarin drug interactions and implement brown bag medication review events as part of community outreach. She has worked with a group of long term care facilities and consultant pharmacists to reduce inappropriate antipsychotic drug use in the long-term care setting.
Nicole has over 15 years’ experience in the long-term care setting serving on both the “provider” pharmacy side and the “consultant pharmacist” side. She has also worked in the ambulatory pharmacy at a large teaching hospital and in the retail setting. In these settings, Nicole led clinical initiatives such as pharmacokinetic dose adjustment programs, therapeutic substitution, development of facility antibiograms and surveillance of antibiotic utilization, and workflow redesign to reduce dispensing errors.
For the past 10 years Nicole has taught a Pharmacy Technician Certificate Program at a local Community College. She participated in curriculum development for expansion of the program and inclusion of medication safety and error prevention education. For the past 7 years Nicole has served as preceptor to 6th year Rutgers PharmD students and recently began working with with Farleigh Dickinson University School of Pharmacy as a preceptor as well.
Speaker Disclosures: All members of the education and online education committees have no financial relationships to disclose. The speakers have no financial relationships to disclose.